NCT02142816

Brief Summary

Targeting the amount of fluid given to measurements of the patients own fluid status during major abdominal surgery has been linked with improved speed of recovery of gut function and reduced length of hospital stay, mortality and complications. Pleth variability index (PVI) offers a noninvasive, risk and pain free alternative to more invasive forms of monitoring to direct how much fluid to give. The study aims primarily to measure and compare how much fluid is given when guided by PVI compared to the established technique; oesophageal doppler during major abdominal surgery. The study will compare 40 patients undergoing major elective abdominal surgery. Patients will receive intraoperative fluid guided by either oesophageal doppler or PVI. Secondarily, the study will examine biochemical markers, length of hospital stay and how frequently complications occur

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 15, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 20, 2014

Completed
Last Updated

May 20, 2014

Status Verified

May 1, 2014

Enrollment Period

1.2 years

First QC Date

May 15, 2014

Last Update Submit

May 15, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference between fluid volumes administered in the intra-operative period

    End of operation

Secondary Outcomes (3)

  • Difference in 24 hour fluid balance

    24 hours

  • Post-operative morbiditiy survey

    7 days

  • Biochemical Markers of Tissue Perfusion

    24 hours

Study Arms (2)

Doppler

ACTIVE COMPARATOR

Fluid directed by oesophageal doppler

Device: Doppler

PVI

ACTIVE COMPARATOR

Fluid therapy directed by Pleth Variability Index

Other: PVI'

Interventions

DopplerDEVICE

Fluid therapy guided by doppler

Doppler
PVI'OTHER

Fluid therapy guided by PVI

PVI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Major abdominal surgery
  • Anaerobic Threshold \>11 ml O2/kg/min
  • VE/VCO2 \<34 OR
  • Low risk according to Consultant anaesthetist

You may not qualify if:

  • Patients age less than 18
  • Patient refused consent
  • Patient unable to give consent
  • Patient has had \<24hrs to consider the Patient information Sheet
  • Contraindication to Doppler Probe being inserted
  • Emergency Procedure
  • Patient has a ASA Grade 5
  • Patient is receiving dialysis treatment
  • Patient has a known hypersensitivity to hydroxyethyl starch or gelatin solutions
  • Patients with renal failure with oliguria or anuria - not related to hypovolaemia
  • Patients with a previously diagnosed dysrhythmia
  • Patients who weight \>100kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

York Teaching Hospital

York, N Yorks, YO318HE, United Kingdom

Location

MeSH Terms

Interventions

Echocardiography, Doppler

Intervention Hierarchy (Ancestors)

EchocardiographyCardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyUltrasonography, DopplerHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • David Yates, MB ChB

    York Teaching Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2014

First Posted

May 20, 2014

Study Start

January 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

May 20, 2014

Record last verified: 2014-05

Locations